Humankind Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Hold
386,000
7.76% 6
2026
Q1
$10.2M Buy
+386,000
New +$11.3M 5.82% 7

Other funds holding ARKG

Humankind Investments's ARKG Position: Q2 2026 in Review

Humankind Investments held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 386,000 shares worth $16.2M. The position accounts for 7.76% of the portfolio, ranked #6.

Humankind Investments first reported a position in ARKG in Q1 2026 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Humankind Investments held 386,000 shares of ARK Genomic Revolution ETF worth $16.2M as of Q2 2026.
  • Humankind Investments left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up 7.76% of Humankind Investments's portfolio in Q2 2026, its #6 holding.
  • Humankind Investments first reported a position in ARK Genomic Revolution ETF in Q1 2026 and has held it in 2 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Humankind Investments's 13F filing for Q2 2026, filed 14 Aug 2026.